Sign in
4/A

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-25-017492

EVP, Chief Commercial Officer acquired 5,689 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Galvin Roy · EVP, Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-16 Grant or award : show line 1 in the form +5,689 12,932 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-16 Grant or award : show line 2 in the form Non-qualified Stock Option (Right to Buy) +12,317 12,317 D
Loading xslF345X05/form4a.xml…